On-the-spot diagnostics

Get accurate results directly to your patients in an hour, without a lab.

See Technology

Product spotlight

InnotiveUTI

Offer point-of-care testing and results in an hour with InnotiveUTI. Our tests accurately diagnose uncomplicated UTIs (uUTI), preventing misprescribed antibiotics and countering antimicrobial resistance.

Close-up of the InnovativeDX diagnostic device, highlighting the sleek orange and white design of its outer casing.

Bacterial infection detection

Close-up of the InnovativeDX diagnostic device, focusing on a circular sensor or button feature on the white and blue panel.

Causative bacterial ID

Close-up of the InnovativeDX diagnostic device tray or platform in orange and white, showcasing the sleek design of the device.

Antimicrobial susceptibility

Innotive Diagnostics
- for better health globally

The wait is over

We provide accurate diagnostics at the point of care: no need to wait days for lab results. This means patients get the right medication, without delay.

A boost for better care outcomes

The current lack of fast antimicrobial susceptibility results in treatment failure and accumulating bills. Our accurate diagnostics eliminate the suffering and the extra cost.

Counter pain 

and AMR

Our fast diagnostics prevent ineffective treatment that prolongs and worsens pain, and misdiagnoses that cause antimicrobial resistance (AMR) worldwide. 

Our vision for the future

We’re working towards a future where everyone has equal access to excellent, fast diagnostics. Our scalable system paves the way towards global antimicrobial stewardship.

“If we don’t act now, our medicine cabinet will be empty and we won’t have the antibiotics we need to save lives.”

CDC Director, Tom Frieden, M.D, M.P.H

“The problem is waiting for the results and you're in pain… and you could be getting worse.”

Patient

“If no action is taken, it has been estimated that drug-resistant infections will kill 10 million people a year by 2050.”

Dame Sally Davies, ex-CMO UK

“UTIs have made me sceptical of doctors in a lot of ways.”

Patient

“It is estimated that nearly 50% of all antimicrobial use in hospitals is unnecessary or inappropriate.”

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives, Clinical Infectious Diseases, IDSA, 2011

“I worry that I’ll get something more serious and I can’t be treated for it because of my previous antibiotic use.”

Patient

“If we don’t act now, our medicine cabinet will be empty and we won’t have the antibiotics we need to save lives.”

CDC Director, Tom Frieden, M.D, M.P.H

“The problem is waiting for the results and you're in pain… and you could be getting worse.”

Patient

“If no action is taken, it has been estimated that drug-resistant infections will kill 10 million people a year by 2050.”

Dame Sally Davies, ex-CMO UK

“If we don’t act now, our medicine cabinet will be empty and we won’t have the antibiotics we need to save lives.”

CDC Director, Tom Frieden, M.D, M.P.H

“The problem is waiting for the results and you're in pain… and you could be getting worse.”

Patient

“If no action is taken, it has been estimated that drug-resistant infections will kill 10 million people a year by 2050.”

Dame Sally Davies, ex-CMO UK

“UTIs have made me sceptical of doctors in a lot of ways.”

Patient

“It is estimated that nearly 50% of all antimicrobial use in hospitals is unnecessary or inappropriate.”

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives, Clinical Infectious Diseases, IDSA, 2011

“I worry that I’ll get something more serious and I can’t be treated for it because of my previous antibiotic use.”

Patient

“If we don’t act now, our medicine cabinet will be empty and we won’t have the antibiotics we need to save lives.”

CDC Director, Tom Frieden, M.D, M.P.H

“The problem is waiting for the results and you're in pain… and you could be getting worse.”

Patient

“If no action is taken, it has been estimated that drug-resistant infections will kill 10 million people a year by 2050.”

Dame Sally Davies, ex-CMO UK

Our industry partners

We received support from the UK public innovation body Innovate UK, participated in the Innovate UK Global Incubator Program with Texas Medical Center Innovation, (TMCi), were longlisted for the Nature Spinoff Award, and are finalists for the Healthtech Challenger Award.
Innotative UK logo
Nature awards the spinoff prize
Bivda
Health tech challengers
TMC innovation
References
Quotes from patients and experts: Scott et al., 2021: Fear and Frustration among Women with Recurrent Urinary Tract Infections: Findings from Patient Focus Groups, 2017